Cargando…
A transcutaneous vaccination system using a hydrogel patch for viral and bacterial infection
One of the most important anthropic missions is preventing the global spread of infectious diseases. Vaccination is the only available preventive treatment for infectious diseases, but the availability of vaccines in developing countries is not adequate. We report a simple, easy-to-use, noninvasive...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114651/ https://www.ncbi.nlm.nih.gov/pubmed/18700159 http://dx.doi.org/10.1016/j.jconrel.2008.07.025 |
_version_ | 1783513933387137024 |
---|---|
author | Ishii, Yumiko Nakae, Tomoko Sakamoto, Fumiko Matsuo, Kazuhiko Matsuo, Keisuke Quan, Ying-Shu Kamiyama, Fumio Fujita, Takuya Yamamoto, Akira Nakagawa, Shinsaku Okada, Naoki |
author_facet | Ishii, Yumiko Nakae, Tomoko Sakamoto, Fumiko Matsuo, Kazuhiko Matsuo, Keisuke Quan, Ying-Shu Kamiyama, Fumio Fujita, Takuya Yamamoto, Akira Nakagawa, Shinsaku Okada, Naoki |
author_sort | Ishii, Yumiko |
collection | PubMed |
description | One of the most important anthropic missions is preventing the global spread of infectious diseases. Vaccination is the only available preventive treatment for infectious diseases, but the availability of vaccines in developing countries is not adequate. We report a simple, easy-to-use, noninvasive hydrogel patch transcutaneous vaccination system. Antigen (Ag)-specific IgG production was induced by applying an Ag-immersed patch to non-pretreated mouse auricle or hairless rat back skin. Immunofluorescence histochemical analysis revealed that Langerhans cells resident in the epidermal layer captured the antigenic proteins delivered by the hydrogel patch, which promoted the penetration of antigenic proteins through the stratum corneum, and that Ag-capturing Langerhans cells migrated into draining lymph nodes. Humoral immunity elicited by our transcutaneous vaccination system demonstrated neutralizing activity in both adenoviral infection and passive-challenge tetanus toxin experiments. The use of this hydrogel patch transcutaneous vaccination system will facilitate the global distribution of effective and convenient vaccines. |
format | Online Article Text |
id | pubmed-7114651 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71146512020-04-02 A transcutaneous vaccination system using a hydrogel patch for viral and bacterial infection Ishii, Yumiko Nakae, Tomoko Sakamoto, Fumiko Matsuo, Kazuhiko Matsuo, Keisuke Quan, Ying-Shu Kamiyama, Fumio Fujita, Takuya Yamamoto, Akira Nakagawa, Shinsaku Okada, Naoki J Control Release Article One of the most important anthropic missions is preventing the global spread of infectious diseases. Vaccination is the only available preventive treatment for infectious diseases, but the availability of vaccines in developing countries is not adequate. We report a simple, easy-to-use, noninvasive hydrogel patch transcutaneous vaccination system. Antigen (Ag)-specific IgG production was induced by applying an Ag-immersed patch to non-pretreated mouse auricle or hairless rat back skin. Immunofluorescence histochemical analysis revealed that Langerhans cells resident in the epidermal layer captured the antigenic proteins delivered by the hydrogel patch, which promoted the penetration of antigenic proteins through the stratum corneum, and that Ag-capturing Langerhans cells migrated into draining lymph nodes. Humoral immunity elicited by our transcutaneous vaccination system demonstrated neutralizing activity in both adenoviral infection and passive-challenge tetanus toxin experiments. The use of this hydrogel patch transcutaneous vaccination system will facilitate the global distribution of effective and convenient vaccines. Elsevier B.V. 2008-10-21 2008-07-23 /pmc/articles/PMC7114651/ /pubmed/18700159 http://dx.doi.org/10.1016/j.jconrel.2008.07.025 Text en Copyright © 2008 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Ishii, Yumiko Nakae, Tomoko Sakamoto, Fumiko Matsuo, Kazuhiko Matsuo, Keisuke Quan, Ying-Shu Kamiyama, Fumio Fujita, Takuya Yamamoto, Akira Nakagawa, Shinsaku Okada, Naoki A transcutaneous vaccination system using a hydrogel patch for viral and bacterial infection |
title | A transcutaneous vaccination system using a hydrogel patch for viral and bacterial infection |
title_full | A transcutaneous vaccination system using a hydrogel patch for viral and bacterial infection |
title_fullStr | A transcutaneous vaccination system using a hydrogel patch for viral and bacterial infection |
title_full_unstemmed | A transcutaneous vaccination system using a hydrogel patch for viral and bacterial infection |
title_short | A transcutaneous vaccination system using a hydrogel patch for viral and bacterial infection |
title_sort | transcutaneous vaccination system using a hydrogel patch for viral and bacterial infection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114651/ https://www.ncbi.nlm.nih.gov/pubmed/18700159 http://dx.doi.org/10.1016/j.jconrel.2008.07.025 |
work_keys_str_mv | AT ishiiyumiko atranscutaneousvaccinationsystemusingahydrogelpatchforviralandbacterialinfection AT nakaetomoko atranscutaneousvaccinationsystemusingahydrogelpatchforviralandbacterialinfection AT sakamotofumiko atranscutaneousvaccinationsystemusingahydrogelpatchforviralandbacterialinfection AT matsuokazuhiko atranscutaneousvaccinationsystemusingahydrogelpatchforviralandbacterialinfection AT matsuokeisuke atranscutaneousvaccinationsystemusingahydrogelpatchforviralandbacterialinfection AT quanyingshu atranscutaneousvaccinationsystemusingahydrogelpatchforviralandbacterialinfection AT kamiyamafumio atranscutaneousvaccinationsystemusingahydrogelpatchforviralandbacterialinfection AT fujitatakuya atranscutaneousvaccinationsystemusingahydrogelpatchforviralandbacterialinfection AT yamamotoakira atranscutaneousvaccinationsystemusingahydrogelpatchforviralandbacterialinfection AT nakagawashinsaku atranscutaneousvaccinationsystemusingahydrogelpatchforviralandbacterialinfection AT okadanaoki atranscutaneousvaccinationsystemusingahydrogelpatchforviralandbacterialinfection AT ishiiyumiko transcutaneousvaccinationsystemusingahydrogelpatchforviralandbacterialinfection AT nakaetomoko transcutaneousvaccinationsystemusingahydrogelpatchforviralandbacterialinfection AT sakamotofumiko transcutaneousvaccinationsystemusingahydrogelpatchforviralandbacterialinfection AT matsuokazuhiko transcutaneousvaccinationsystemusingahydrogelpatchforviralandbacterialinfection AT matsuokeisuke transcutaneousvaccinationsystemusingahydrogelpatchforviralandbacterialinfection AT quanyingshu transcutaneousvaccinationsystemusingahydrogelpatchforviralandbacterialinfection AT kamiyamafumio transcutaneousvaccinationsystemusingahydrogelpatchforviralandbacterialinfection AT fujitatakuya transcutaneousvaccinationsystemusingahydrogelpatchforviralandbacterialinfection AT yamamotoakira transcutaneousvaccinationsystemusingahydrogelpatchforviralandbacterialinfection AT nakagawashinsaku transcutaneousvaccinationsystemusingahydrogelpatchforviralandbacterialinfection AT okadanaoki transcutaneousvaccinationsystemusingahydrogelpatchforviralandbacterialinfection |